Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2025-12-24 @ 9:08 PM
NCT ID:
NCT06866704
Eligibility Criteria:
Inclusion Criteria:
1. Persistent atrial fibrillation;
2. Ejection fraction \>30%;
3. NYHA functional class I-III;
4. Left atrial diameter \<55 mm on echocardiography;
5. Signed informed consent form;
Exclusion Criteria:
1. Pregnant or lactating women;
2. Patients with a life expectancy of less than 2 years due to non-cardiovascular factors;
3. Uncontrolled hyperthyroidism, severe liver or kidney dysfunction;
4. History of atrial fibrillation ablation;
5. History of heart transplantation, complex congenital heart disease, or rheumatic heart disease;
6. Contraindications to contrast agents, radiofrequency ablation, antiarrhythmic drugs, or anticoagulants;
7. Acute coronary syndrome, cardiac surgery, angioplasty, or cerebrovascular 8.accident within 12 weeks prior to enrollment;
9.Other conditions deemed unsuitable for participation by investigators; 10.Participation in other clinical trials.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT06866704
Study Brief:
Protocol Section:
NCT06866704